Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds.

about

Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds.

Item

http://www.wikidata.org/entity/Q38885397

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Optimisation of percutaneous c ...... s for bioresorbable scaffolds.

@en

type

Item

label

Optimisation of percutaneous c ...... s for bioresorbable scaffolds.

@en

prefLabel

Optimisation of percutaneous c ...... s for bioresorbable scaffolds.

@en

P1476

Optimisation of percutaneous c ...... s for bioresorbable scaffolds.

@en

P2093

Christos V Bourantas

http://www.w3.org/2001/XMLSchema#string

Hiroki Tateishi

http://www.w3.org/2001/XMLSchema#string

Mustafa Yılmaz

http://www.w3.org/2001/XMLSchema#string

Pannipa Suwannasom

http://www.w3.org/2001/XMLSchema#string

Patrick W Serruys

http://www.w3.org/2001/XMLSchema#string

Yohei Sotomi

http://www.w3.org/2001/XMLSchema#string

Yoshinobu Onuma

http://www.w3.org/2001/XMLSchema#string

P2860

Lessons from the GHOST-EU registry

Vascular responses to drug eluting stents: importance of delayed healing

Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes

Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.

Routine intravascular ultrasound guidance of percutaneous coronary intervention: a critical reappraisal.

P304

1053-1070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14779072.2016.1208084

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erhan Tenekecioglu

Mohammad Abdelghani

P577

2016-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27376592

http://www.w3.org/2001/XMLSchema#string